glp 1 agonist alcohol use disorder Can semaglutide help reduce craving and consumption in adults with alcohol disorder?, A randomized clinical trial published in JAMA Psychiatry offers preliminary evidence. , 🔗 Read the IUPHAR review – Glucagon-like peptide-1

Tirzepatide drops and tirzepatide tablet formulations are also in development, with Eli Lilly pursuing an oral tirzepatide that showed promising results in early trials

To view or add a comment, sign in 2,164 followers

However, semaglutide may complement your current treatment by reducing inflammation and joint stress through weight loss

Emerging research suggests allulose may stimulate modest increases in GLP-1 hormone release through the intestinal L-cells, but the magnitude of this effect remains far smaller than therapeutic GLP-1 medications

Individuals with a personal or family history of Medullary Thyroid Cancer or Multiple Endocrine Neoplasia Type 2 (MEN 2) should not take a GLP-1 agonist